HMG CoA reductase inhibitors and PPAR-alpha activators: are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials? (Q44166055)
Jump to navigation
Jump to search
scientific article published in November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HMG CoA reductase inhibitors and PPAR-alpha activators: are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials? |
scientific article published in November 2002 |
Statements
1 reference
HMG CoA reductase inhibitors and PPAR-alpha activators: are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials? (English)
1 reference
Jean-Charles Fruchart
1 reference
Patrick Duriez
1 reference
1 November 2002
1 reference
1 reference
Identifiers
1 reference